YF Capital — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
A life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.
BiotechDeep TechHardwareMedical DevicesSemiconductors
Co-investorsFoothill VenturesCBC Group
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.
BiotechHealthtechLongevityWaltham, US
Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)
Co-investorsARCH Venture PartnersF-Prime CapitalYuanBio Venture CapitalCBC GroupEight Roads VenturesFuture Innovation+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.